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INTRODUCTION
Fibronectin is high molecular weight glycoprotein found in extracellular fluids, connective tissues, and associated with basement membranes (1, 2) . In cell culture, fibronectin is present in cell layers of substrateattached cells and is organized into an extracellular fibrillar matrix (3) (4) (5) (6) . Collagen, a second component Dr. Mosher was an Established Investigator ofthe American Heart Association and its Wisconsin affiliate during the course of this study.
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of the matrix (7, 8) , binds to fibronectin (9) (10) (11) (12) . A specific region ofthe type I collagen al(I) chain, which is generated by cyanogen bromide cleavage and designated al(l)-CB7, comprises residues 552-822 and contains the principal binding site for fibronectin (11, 12) . Ultrastructural localization of fibronectin and collagen at various times after subculture of human skin fibroblasts suggests that fibronectin serves as a template or scaffolding for collagen fiber formation.' Transglutaminases are a class of calcium iondependent enzymes that catalyze an acyl transfer reaction which involves glutaminyl residues in proteins and peptides as acyl donors and a variety ofprimary amines, including lysyl residues, as acyl acceptors. Monosubstituted y-amide bonds are thus formed. By this reaction, transglutaminases can catalyze the incorporation of E-(y-glutamyl)-lysine linkages between proteins. Inasmuch as specific glutaminyl residues are susceptible to the action of transglutaminases and accepting lysyl residues must be in favorable stereochemical juxtaposition, this cross-linking is a highly specific reaction. As recently reviewed by Folk and Finlayson (13) , transglutaminases are widespread and are thought to catalyze many biologically important reactions: the cross-linking of vertebrate fibrin by plasma transglutaminase (blood coagulation Factor XIIIa), clotting of seminal plasma by transglutaminase from the anterior prostate gland of rodents, cross-linking of hair proteins by hair follicle transglutaminase, cross-linking of keratin by epidermal transglutaminase, and clotting of lobster fibrinogen.
In this paper, we demonstrate that plasma transglutaminase (Factor XIIIa) catalyzes the cross-linking of fibronectin and collagen. We speculate that this reaction may be important for wound healing and tissue repair. Purification of proteins. Human fibrinogen, Factor XIII, and fibronectin were purified as described previously (15) . Fibronectin was also purified from whole plasma by affinity chromatography on immobilized gelatin (16, 17) . Adsorbed fibronectin was eluted from the column with 1 M sodium bromide, pH 5.3 (18) , dialyzed against Tris-buffered saline, pH 7.4, and concentrated by precipitation with 40% ammonium sulfate. Fibrinogen, Factor XIII, and fibronectin were >95% pure as assayed by sodium dodecyl sulfate-polyacrylamide gel electrophoresis. However, the fibrinogen and fibronectin preparations contained residual Factor XIII activity (as assayed by ability to cross-link fibrin) unless treated with 3.3 M urea (19) .
Rat (from lathyritic animals) and fetal calf skin type I collagen, calf skin type III collagen, al(I) chains, and cyanogen bromide peptides of al(I) chains were prepared as described previously (11, 12) . Ascaris collagen (20) was a gift of Ms. C. Sullivan, National Institute of Dental Research, Bethesda, Md.
Radiolabeling ofproteins. al(I)-CB7 was iodinated by the Bolton-Hunter reagent (21) . al(I)-CB7 was dissolved in 0.1 M sodium borate, pH 8.5, at a concentration of 2 mg/mil. Ice-cold solution, 400 ,l, was added to 1 mCi ofBolton-Hunter reagent, previously dried from benzene in the reaction vial as recommended by the manufacturer. After 15 min at 0°C, the reaction was terminated by adding 1 ml of 0.2 M glycine in borate buffer, pH 8. Cross-linking reactions. Factor XI1a-mediated crosslinking was performned in 10 mM Tris-chloride, 140 mM sodium chloride, pH 7.4 (Tris-buffered saline), containing the indicated amount of calcium chloride. Proteins to be added were in Tris-buffered saline, with the exception of types I and III collagen. In some experiments, the collagens were dissolved in 100 mM acetic acid, the solutions were dialyzed against 5 mM acetic acid, and insoluble protein was removed by centrifugation at 110,000g for 90 min. In other experiments, the collagens were dissolved in 100 mM acetic acid and dialyzed at 40C against 0.14 M potassium phosphate, pH 7.4, and then against 0.4 M sodium chloride, pH 7.4. Visible gel formation did not occur when the various collagen preparations were cross-linked to fibronectin. The cross-linking reactions were stopped by addition of an equal volume of 2% sodium dodecyl sulfate and 2% 3-mercaptoethanol followed by heating for 3 min at 95°C.
Sodium dodecyl sulfate-polyacrylamide gel electrophoresis. Polyacrylamide gel electrophoresis in sodium dodecyl sulfate was performed in cylindrical gels (22) or on discontinuous slab gels (23) . Proteins were stained with Coomassie brilliant blue (24) and photographed with Polaroid 665 positive-negative film (Polaroid Corp., Cambridge, Mass.). Bands corresponding to the chains of collagen stained redder than the bands corresponding to fibronectin or marker proteins. The metachromasia was corroborated by spectroscopy of gel slices (25) .
Slabs containing 1251-proteins were dried and analyzed by autoradiography with Kodak Royal X-Omat R x-ray film (Eastman Kodak Co., Rochester, N. Y.). Densitometry was performed on a Joyce-Loebl densitometer (Joyce, Loebl and Co., Ltd., Gateshead-on-Tyne, England).
RESULTS
Incubation of fibronectin, the al(I) chain of type I collagen, and Factor XIIIa at 20°C resulted in the formation ofhigh molecular complexes (Fig. 1) . The apparent molecular weights of-the complexes, ascertained by sodium dodecyl sulfate-polyacrylamide gel electrophoresis after reduction, were 3.1 x 105, -5 x 105, and >1 x 106. The complexes were not formed if the incubation mixture lacked fibronectin, al(I), thrombin (needed to activate Factor XIII), calcium ion, or Factor XIII. The complexes were destroyed by trypsin [which cleaved both a I(I) chains and fibronectin] and bacterial FIGURE 1 Factor XIII-mediated cross-linking between fibronectin and al(l) collagen chains. The reduced products of five different incubations were analyzed by sodium dodecyl sulfate-polyacrylamide gel electrophoresis on 4% cylindrical gels. Each incubation was for 2 h at 20'C. Incubation 1 contained 490 gsg/ml fibronectin, 270 jsg/ml al(I), 1 U/ml thrombin, 21 Asg/ml Factor collagenase [which cleaved only al(I) chains] (Fig. 2) . Although the complexes were sensitive to collagenase, the color after staining with Coomassie brilliant blue R-250 was blue and typical of fibronectin rather than collagen (Fig. 3) . These results strongly stuggest that Factor XIlIa catalyzes the cross-linking of fibronectin to acl(I).
Cross-linking at 370C could also be demonstrated between fibronectin and types I and III collagen (Figs. 4  and 5 ). Very high molecular weight complexes formed within 90 min (Fig. 4) . At intermediate time points, complexes with apparent molecular weights of 3.1 and 5 x 105 were present. In contrast to cross-linking between fibronectin and al(I) chains, which occurred at 220 or 370C, cross-linking between fibronectin and types I or III collagen could only be demonstrated at 37°C (Fig. 5 ). There were no cross-linking between fibronectin and Ascaris collagen (figure not shown).
A preparation of al(I)-CB7, the cyanogen bromide fragment of'al(L) which is the most effective in compet-_4 -,.
- and types I or III collagen. 300 ug/ml fibronectin, 25 iLg/ml Factor XIII, 1 U/ml thrombin, and 10 mM calcium ion were incubated at 37°C with either 200 ,ug/ml type I collagen (gels 1-4), or 200 ,tg/ml type III collagen (gels [5] [6] [7] [8] . The collagens were prepared in 5 mM acetic acid as described in Methods.
Incubations were sampled after 0 (gels i and 5), 5 (gels 2 and 6), 15 (gels 3 and 7), and 90 (gels 4 and 8) min ofincubation, and the proteins were analyzed as described for Fig. 1 ,ug/ml fibronectin, 25 jig/ml Factor XIII, 1 U/ml thrombin, and 10 mM calcium ion were incubated for 2 h with 500 ,ug/ml type I collagen (gels 1-3), 500 fig/ml type III collagen (gels 5-7), or 500 ,ug/ml al(I) chains (gels 9-11). The collagens and al(I) chains were prepared by se(quential dialysis in the cold against acetic acid, phosphate, and Tris-buffered saline as described in Methods. Temperatures of incubations were 00 (gels, 1, 5, and 9), 22°(gels, 2, 6, and 10), or 37°C (gels 3, 7, and 11). Gels 4, 8, 12, and 13 contain type I collagen, type III collagen, al(I) chains, and fibronectin, respectively; each protein was incubated for 120 mim at 37°C with Factor XIII, thrombin, and calcium ion. The minor blands of the same molecular weight as fibronectin in gels 4 anid 8 were metachromatic and represent the a-components of types I and III collagen. Gels 14 and 15 contained nonreduced fibronectin and molecular weight markers as in Fig. 4 .
ing for binding of fibronectin to collageni (11, 12) , was iodinated with the Bolton-Hunter reagent. Two radioactive bands were found (Fig. 6 ). The major band had an apparent molecular weight of 3.3 x 10. The minor band had an apparent molecular weight of 2.9 x 104 and did not comigrate with a preparation of al(I)-CB8, which is also effective in competing for binding of fibronectin to collagen (11, 26) . We believe that the minor band is a breakdown product of al(I)-CB7. Both radioactive bands were diminished when the iodinated preparation was incubated with fibronectin in the presence of Factor XIIIa. This was accompanied by the appearance of' radioactive bands of higher molecular weight (Fig. 6, lower) . The major higher molecular weight radioactive band had anl apparent molecular weight of 2.2 x 105, and the molecular weights of' the minor higher molecular weight bands were >4.0 x 105. Protein-staining bands (Fig. 6, upper) of molecular weights 4 .0 x 105 and greater also appeared. The crosslinking reaction was complete within 10 min at 37°C (Fig. 6 ) and within 30 min at 0°C (figure not shown).
The cross-linking of 1251-al(I)-CB7 to fibronectin FIGURE 6 Factor XlIla-mediated cross-Iinikinig between fibronectin and '21I-al(I)-CB7 of' al(l) collagen chain.s. The reduced prodltucts of six differenit incul)ations wvere analyzed )v sodiulm dodecyl sulfate-polyacrylamide electrophoresis throuigh at 3%/8% dlisconitinutiouis slab gel. The slabl) was ainalyzed for stainal)le proteini (above) andl by auitoradiograiphy (below'). The 3% stacking gel Nwas lost dtlring processing. The front is at the bottom of the gel aindl cani be seen by 1)oth protein staining (above) a(wnl autoradiograph y (below). Incubations 1-6 were for 2 h at 37°C. Incubation 1 contained 1,500 ,ug/ml fibronectin, )0.6 yg/ml '251-al(I)-CB7 (2.6 x 1(5 epimi/miii), 26 ,tg/ml Factor XIII, 1 UI/ml thrombin, aindl 5 (Figs. 4 and 5) , the percent inhibition for the collagens is not a true estimate.
Lastly, we investigated the effect of adding various amounts of al(I)-CB7 peptides on the cross-linking offibronectin to the a-chain of fibrin. al(I)-CB7, in twoto sixfold excess of fibronectin, inhibited the crosslinking of fibronectin to the a-chain of fibrin at 40C (Fig. 7) . Thus, this collagen peptide can interfere with the fibrin-fibronectin cross-linking just as fibrin interferes with al(I)-CB7-fibronectin cross-linking.
DISCUS SION
Fibronectin is one of a limited number of plasma proteins which contain glutaminyl residues susceptible to the action of Factor XIIIa (19, 27, 28) . Factor XIIIa, in the presence of reagents containing sulfhydryl groups (19) , and guinea pig liver transglutaminase (29) catalyze the cross-linking of fibronectin to itself. Factor XIIIa also catalyzes the cross-linking of fibronectin to the a-chain of fibrin (19, 30) and causes the serum concentration of fibronectin to be less than the plasma concentration (27, 31) . When denatured collagen is present during clotting, the loss of fibronectin into the fibrin clot is less (9) . Conversely, fibrinogen inhibits the binding of fibronectin to denatured collagen (9) .
Factor XIIIa also acts upon fibronectin associated with cell surfaces of cultured fibroblasts (32) and readily cross-links labeled cell surface fibronectin to form a very high molecular weight complex (15) . Such crosslinking may take place in culture in the absence of exogenous Factor XIII (33) . As discussed in the Introduction, the bulk of external fibronectin of cultured fibroblasts is localized, along with collagen, in an extracellular fibrillar matrix.
Our experiments demonstrate that two forms of collagen which are known to bind to fibronectin, the al(I) chain of type I collagen and cyanogen bromide fragment 7 of the al(I) chain (11, 12, 26) , can be crosslinked to fibronectin by Factor XIIIa. A second component of the iodinated al(I)-CB7 preparation, tentatively identified as a breakdown product of al(I)-CB7, also was cross-linked to fibronectin. Ascaris collagen, which is different from vertebrate collagen (20) and is inactive in cell adhesion assays of fibronectin activity (34) (41) . Therefore, it is likely that there is local denaturation oftypes I and III collagens at 37°C, especially at the collagenase-sensitive site within al(I)-CB7, which lacks proline and hydroxyproline over a span of 12 residues (12) .
Complex formation and cross-linking between fibronectin and collagen may be of considerable physiological significance. Ultrastructural localization of fibronectin and collagen at various times after subculture of human skin fibroblasts indicates that the early matrix of 2-to 10-d-old cells consists of polymerized fibronectin to which nonhelical collagen is bound and that the matrix of4-to 8-wk-old cells consists ofperiodic collagen fibrils to which fibronectin is bound.1 2 Thrombin and other growth factors are known to induce the synthesis of fibronectin (42) and collagen (43, 44) . Fibronectin has been noted around new fibroblasts of skin scar tissue (45) . Failure of Factor XIIIa to crosslink fibronectin to collagen during wound healing and tissue remodeling may explain the observations that patients deficient in Factor XIII often suffer from poor wound healing and have difficulty carrying pregnancies to term (46) .
